Related Experiment Video
Updated: Aug 20, 2026

Detection of Functional Matrix Metalloproteinases by Zymography
Published on: November 8, 2010
Expression of matrix metalloproteinases in patients with Wegener's granulomatosis
V Bjerkeli1, B Halvorsen, J K Damås
1Research Institute for Internal Medicine, Medical Department, Rikshospitalet University Hospital, N-0027 Oslo, Norway. vigdis.bjerkeli@klinmed.uio.no.
Background:
Enhanced activity of matrix metalloproteinases (MMPs) has been reported to have a pathogenic role in several diseases such as cancer and cardiovascular disorders, and seems also to play a part in certain autoimmune diseases.
Objective:
To examine whether enhanced MMP activity may also have a role in the pathogenesis of Wegener's granulomatosis (WG).
Methods:
In a study group of 15 patients with WG and 15 controls, plasma levels and gene expression were measured in freshly isolated peripheral blood mononuclear cells (PBMCs) of several MMPs and their endogenous inhibitors (that is, tissue inhibitors of metalloproteinases (TIMPs)) by enzyme immunoassays and RNase protection assay, respectively.
Results:
Whereas patients with WG in remission had enhanced gene expression of several MMPs and TIMPs in PBMCs, those with active disease had a selective up regulation of MMP-2 and MMP-8 compared with healthy controls, and a down regulation of TIMP-1 and TIMP-3 compared with other patients with WG. Moreover, plasma levels of TIMP-1 and MMP-8 correlated significantly with C reactive protein levels, further supporting an association between activation of the MMP/TIMP system and disease activity in WG. Finally, these changes in MMP/TIMP expression in WG were accompanied by increased total MMP activity in PBMC supernatants, particularly in those with active disease, suggesting a matrix degrading net effect.
Conclusion:
These findings suggest that disturbed MMP and TIMP activity has a role in the pathogenesis of WG.
Insights
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) show altered activity in Wegener's granulomatosis (WG). This suggests their involvement in the autoimmune disease's pathogenesis.
Area of Science:
- Immunology
- Pathophysiology
- Biochemistry
Background:
- Matrix metalloproteinases (MMPs) are implicated in the pathology of various diseases, including cancer, cardiovascular disorders, and autoimmune conditions.
- The specific role of MMPs in Wegener's granulomatosis (WG), a systemic autoimmune vasculitis, requires further elucidation.
Purpose of the Study:
- To investigate the potential role of enhanced MMP activity in the pathogenesis of Wegener's granulomatosis (WG).
Main Methods:
- Assessed plasma levels and gene expression of MMPs and their inhibitors (TIMPs) in 15 WG patients and 15 controls.
- Utilized enzyme immunoassays and RNase protection assays on peripheral blood mononuclear cells (PBMCs).
Main Results:
- Patients with active WG showed selective upregulation of MMP-2 and MMP-8, and downregulation of TIMP-1 and TIMP-3 in PBMCs compared to controls and WG patients in remission.
- Plasma levels of TIMP-1 and MMP-8 correlated with C-reactive protein levels, linking MMP/TIMP system activation to WG disease activity.
- Increased total MMP activity was observed in PBMC supernatants, particularly in active WG patients, indicating a net matrix-degrading effect.
Conclusions:
- Disturbed activity of MMPs and TIMPs is suggested to play a role in the pathogenesis of Wegener's granulomatosis.
- These findings highlight the MMP/TIMP system as a potential therapeutic target in WG.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Chronic Inflammation: Introduction
The Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Extracellular Matrix
Matrix Proteoglycans and Glycoproteins